|
|
|
Before COVID-19 |
Before COVID-19 |
COVID-19 Period |
COVID-19 Period |
|
|
|
|
N |
% |
N |
% |
p
value |
Diagnosis |
Invasive ductal carcinoma |
70 |
70 |
94.5 |
66 |
90.4 |
0.270b |
|
Invasive lobular carcinoma |
3 |
3 |
4.1 |
2 |
2.7 |
|
|
Mixed |
1 |
1 |
1.4 |
5 |
6.8 |
|
ER |
Negative |
11 |
11 |
14.9 |
11 |
15.1 |
0.972a |
|
Positive |
63 |
63 |
85.1 |
62 |
84.9 |
|
PR |
Negative |
15 |
15 |
20.3 |
14 |
19.2 |
0.868a |
|
Positive |
59 |
59 |
79.7 |
59 |
80.8 |
|
HER-2 |
Negative |
58 |
58 |
78.4 |
55 |
75.3 |
0.663a |
|
Positive |
16 |
16 |
21.6 |
18 |
24.7 |
|
Neoadjuvant Therapy |
No |
68 |
68 |
91.9 |
67 |
91.8 |
0.980a |
|
Yes |
6 |
6 |
8.1 |
6 |
8.2 |
|
İncreased uptake in Lymphoscintigraphy |
Not Observed |
1 |
1 |
1.4 |
12 |
16.4 |
0.001a |
|
Observed |
73 |
73 |
98.6 |
61 |
83.6 |
|
Axillary dissection |
Not performed |
47 |
47 |
63.5 |
51 |
72.9 |
0.229a |
|
Performed |
27 |
27 |
36.5 |
19 |
27.1 |
|
T Stage |
1 |
30 |
30 |
43.5 |
23 |
35.4 |
0.497b |
|
2 |
37 |
37 |
53.6 |
38 |
58.4 |
|
|
3 |
2 |
2 |
2.9 |
4 |
6.2 |
|
Sentinel Lymph Node Detection Status |
Not found |
2 |
2 |
2.7 |
7 |
9.6 |
0.097b |
|
Found |
72 |
72 |
97.4 |
66 |
90.4 |
|